Seaport Therapeutics Inc. (SPTX) Live Share Price, Invest From India

Seaport Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$16.91
Day's Price Range
$18.28
$18.17
6.93%
Downside
0.61%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$18.17
100.00%
Downside
-100.00%
Upside

Seaport Therapeutics Inc. share price movements today

Previous Close: $17.10
Open: $17.44
Volume: 604.4K
Day's Low - High: $16.91 - $18.28

Seaport Therapeutics Inc. Historical Returns

1 Month Return: + 16.03 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Seaport Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Seaport Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$941.1M

EPS (TTM)

-6.5002

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-28.08%

Seaport Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Seaport Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Seaport Therapeutics Inc.	NA	$941.1M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Indian Investors' Interest in Seaport Therapeutics Inc. Stock

Search interest for Seaport Therapeutics Inc. Stock has increased by 356% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:356% versus previous 30 day period

Seaport Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-16	-27
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-13	-24
Income Tax Expense	-	-
Net Income	-13	-25
Net Profit Margin	0.00%	0.00%

Seaport Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-52	-87
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	1
Income Before Tax	-46	-74
Income Tax Expense	-	-
Net Income	-46	-74
Net Profit Margin	0.00%	0.00%

Seaport Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-25
Operating Cash Flow	-20
Investing Cash Flow	-
Financing Cash Flow	0
Change in Cash	6

Seaport Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-74
Operating Cash Flow	-77
Investing Cash Flow	-
Financing Cash Flow	0
Change in Cash	-263

Insights on Seaport Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, SPTX stock has moved up by 16.0%

About Seaport Therapeutics Inc.

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.

Organisation	Seaport Therapeutics Inc.
Headquarters	101 Seaport Blvd., Boston, MA, United States, 02210-2186
Industry	Biotechnology
CEO	Ms. Daphne Zohar
E-voting on shares	Click here to vote

Key Management of Seaport Therapeutics Inc.

Name	Title
Dr. Steven M. Paul M.D.	Founder & Non-Employee Chair of the Board
Ms. Daphne Zohar	Founder, CEO, President & Director
Dr. Michael Cunyuan Chen Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Antony Loebel M.D.	Chief Medical Officer & President of Clinical Development
Ms. Lauren A. White M.B.A.	Chief Financial Officer
Ms. Lana Gladstein J.D.	General Counsel

FAQs

What is Seaport Therapeutics Inc. share price today?

Seaport Therapeutics Inc. share price today is $18.17 as on June 19, 2026 at 8:46 am IST at the close of the market. Seaport Therapeutics Inc. share today touched a day high of $18.28 and a low of $16.91.

What is the 52 week high and 52 week low for Seaport Therapeutics Inc. share?

Seaport Therapeutics Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Seaport Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $18.17,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Seaport Therapeutics Inc.'s market capitalisation today?

Seaport Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Seaport Therapeutics Inc. Stock (SPTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Seaport Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seaport Therapeutics Inc. Shares that will get you 0.0826 shares as per Seaport Therapeutics Inc. share price of $18.17 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Seaport Therapeutics Inc. Stock (SPTX) from India?

Indian investors can start investing in Seaport Therapeutics Inc. (SPTX) shares with as little as ₹94.31 or $1 (as of June 19, 2026 at 8:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Seaport Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 8:43 pm IST). Based on Seaport Therapeutics Inc. share’s latest price of $18.17 as on June 19, 2026 at 8:46 am IST, you will get 0.5504 shares of Seaport Therapeutics Inc.. Learn more about fractional shares .